In the initial Gruppo Italiano per lo Studio della Sopravvivenza nell’infarto miocardico (GISSI) trial, patients taking n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction had a lower mortality rate than those in the control group. The purpose of the GISSI-HF trial was to determine if PUFA could improve morbidity and mortality in patients with symptomatic […]